<DOC>
	<DOCNO>NCT01929044</DOCNO>
	<brief_summary>The aim study assess efficacy Buscopan® ( hyoscine butylbromide ) comparison 654-II ( anisodamine ) acute gastric intestinal spasm-like pain .</brief_summary>
	<brief_title>Efficacy Buscopan® Comparison With 654-II ( Anisodamine ) Acute Gastric Intestinal Pain</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<mesh_term>Anisodamine</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients must sign date Informed Consent consistent International Conference Harmonisation ( ICH ) /Good Clinical Practice ( GCP ) guideline local regulation prior participation trial . 2 . Patients must agree cooperate trial evaluation perform require task . 3 . Patients acute gastric intestinal spasmlike pain ( without severe vomit surgical acute abdomen ) . 4 . Male female patient age 18 70 year . 5 . The pain intensity upon screen least point 6 010 numerical rating scale ( NRS ) . Exclusion criterion : 1 . Patients follow concomitant disease eligible enrollment : Painful gastric intestinal spasm organic origin Crohn 's disease , ulcerative colitis , lactose intolerance , gastrointestinal perforation , suspect gastrointestinal perforation peritoneal effusion . Pain related malignancy . Patients severe pain state organic origin . Mechanical stenosis gastrointestinal tract , megacolin . Urinary retention associate mechanical stenosis urinary tract . Narrowangled glaucoma . Tachyarrhythmia . Myasthenia gravis . MeulengrachtGilbert syndrome . Known depression know mental illness , anxiety disturbance . 2 . Patients take follow concomitant medication within 7 halflife concomitant medication ( duration take concomitant medication attend trial le 7 halflife ) eligible enrollment : Analgesics , Spasmolytics , Anticholinergics Affecting gastrointestinal motility , propantheline , metoclopramide , cisapride , loperamide , diphenoxylate , opioid analgesic , antacid ulcer treatment Regular administration laxatives Narcotics Antidepressant treatment treatment psychoactive drug 3 . Pregnancy and/or lactation plan pregnancy ; 4 . Known hypersensitivity Nbutylscopolammonium bromide 5 . Alcohol , drug abuse . 6 . Simultaneous participate another clinical trial , discontinue another clinical trial randomization ( administration study medication ) ; moreover , case screening failure premature discontinue trial , repeat enrollment forbidden . 7 . Unwilling unable complete entire trial procedure accord protocol . 8 . In investigator 's opinion , patient proper trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>